PEABODY, Mass., Dec. 8, 2011 (GLOBE NEWSWIRE) — Analogic Corporation (Nasdaq:ALOG), enabling the world’s medical imaging and aviation security technology, announced today that its Board of Directors has authorized the repurchase of up to $30 million of the Company’s common stock.
The repurchase program will be funded using the Company’s available cash. As of October 31, 2011, Analogic had cash and cash equivalents of approximately $151 million. The Company had approximately 12.2 million shares of common stock outstanding as of November 24, 2011.
Jim Green, Analogic’s president and CEO, commented, “We believe this stock repurchase is an appropriate use of our available funds and is in the best interest of our company and shareholders. We remain bullish on our future.”
Statements in this press release regarding the Company’s intention to repurchase shares of its common stock under the stock repurchase program, the intended use of any repurchased shares, and the source of funding are forward-looking statements. There are a number of important factors that could cause actual events to differ materially from those suggested or indicated by such forward-looking statements. These include, among others, the market price of the Company’s stock prevailing from time to time, the Company’s cash flows from operations, general economic conditions, and other factors identified in the Company’s most recent Annual Report on Form 10-K filed with the SEC.
Analogic (Nasdaq:ALOG) provides leading-edge healthcare and security technology solutions to advance the practice of medicine and save lives. We are recognized around the world for advanced imaging systems and technology that enable computed tomography (CT), ultrasound, digital mammography, and magnetic resonance imaging (MRI), as well as automated threat detection for aviation security. Our CT, MRI, digital mammography, and ultrasound transducer products are sold to original equipment manufacturers (OEMs), providing state-of-the-art capability and enabling them to enter new markets and expand their existing market presence. Our market-leading BK Medical branded ultrasound systems, used in procedure-driven markets such as urology, guided surgery, and anesthesia, are sold to clinical end users through our direct sales force. For over 40 years we’ve enabled customers to thrive, improving
the health and ensuring the safety of people around the world. Analogic is headquartered just north of Boston, Massachusetts.
For more information, visit www.analogic.com
CONTACT: Mark Namaroff Director of Investor Relations & Corporate Marketing 978-326-4058 firstname.lastname@example.org